AC Immune SA (ACIU)

NASDAQ: ACIU · Real-Time Price · USD

2.840

-0.070 (-2.41%)

At close: Mar 4, 2026, 4:00 PM EST

2.827

-0.013 (-0.46%)

After-hours: Mar 4, 2026, 7:26 PM EST

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Discovering and Developing Therapeutic and Diagnostic Products	27.31M	14.80M	3.94M		15.43M	110.46M
Discovering and Developing Therapeutic and Diagnostic Products Growth	84.51%	276.14%	-		-86.03%	1498.03%
Total	27.31M	14.80M	3.94M		15.43M	110.46M
Total Growth	84.51%	276.14%	-		-86.03%	1498.03%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Switzerland	27.31M	14.80M	3.94M		15.43M	110.46M
Switzerland Growth	84.51%	276.14%	-		-86.03%	1498.03%
Total	27.31M	14.80M	3.94M		15.43M	110.46M
Total Growth	84.51%	276.14%	-		-86.03%	1498.03%

Source: S&P Global Market Intelligence.